Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvie Rottey

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Acta Clinica Belgica|February 3, 2017
Checkpoint inhibition: new treatment options in urologic cancerDaan Joost De Maeseneer, Brant Delafontaine, Sylvie Rottey
European Heart Journal Open|October 14, 2024
Anticoagulant-related bleeding as a sign of underlying tumoural lesions in patients with atrial fibrillation: a nationwide cohort studyKristiaan Proesmans, Maxim Grymonprez, Sylvie Rottey, et al.
Current Opinion in Oncology|February 19, 2011
Modern treatment for nasopharyngeal carcinoma: current status and prospectsSylvie Rottey, Indira Madani, Philippe Deron, et al.
Expert Review of Anticancer Therapy|December 30, 2017
Pembrolizumab for the treatment of bladder cancerNora Sundahl, Sylvie Rottey, Daan De Maeseneer, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 9, 2019
Prostate Protein N-Glycosylation Profiling by Means of DNA Sequencer-Assisted Fluorophore-Assisted Carbohydrate ElectrophoresisTijl Vermassen, Nico Callewaert, Sylvie Rottey, et al.
International Journal of Clinical Pharmacy|February 24, 2022
The use of national reimbursement reports to support formulary decisions of the hospital's Drug and Therapeutics Committee: a comparative analysisBarbara Claus, Sabrina Commeyne, Marc Van de Casteele, et al.
Acta Clinica Belgica|July 19, 2016
Abscopal effect in metastatic renal cell carcinomaMieke Van de Walle, Jan Demol, Lorenzo Staelens, et al.
Acta Clinica Belgica|November 1, 2019
Targeting FGFR in bladder cancer: ready for clinical practice?Stijn De Keukeleire, Daan De Maeseneer, Celine Jacobs, et al.
Urologic Oncology|February 25, 2015
Battling resistance mechanisms in antihormonal prostate cancer treatment: Novel agents and combinationsDaan Joost De Maeseneer, Charles Van Praet, Nicolaas Lumen, et al.
Acta Clinica Belgica|June 30, 2016
Therapeutic approaches in clear cell and non-clear cell renal cell carcinomaT Vermassen, A De Meulenaere, M Van de Walle, et al.
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Acta Clinica Belgica|February 3, 2017
Checkpoint inhibition: new treatment options in urologic cancerDaan Joost De Maeseneer, Brant Delafontaine, Sylvie Rottey
European Heart Journal Open|October 14, 2024
Anticoagulant-related bleeding as a sign of underlying tumoural lesions in patients with atrial fibrillation: a nationwide cohort studyKristiaan Proesmans, Maxim Grymonprez, Sylvie Rottey, et al.
Current Opinion in Oncology|February 19, 2011
Modern treatment for nasopharyngeal carcinoma: current status and prospectsSylvie Rottey, Indira Madani, Philippe Deron, et al.
Expert Review of Anticancer Therapy|December 30, 2017
Pembrolizumab for the treatment of bladder cancerNora Sundahl, Sylvie Rottey, Daan De Maeseneer, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 9, 2019
Prostate Protein N-Glycosylation Profiling by Means of DNA Sequencer-Assisted Fluorophore-Assisted Carbohydrate ElectrophoresisTijl Vermassen, Nico Callewaert, Sylvie Rottey, et al.
International Journal of Clinical Pharmacy|February 24, 2022
The use of national reimbursement reports to support formulary decisions of the hospital's Drug and Therapeutics Committee: a comparative analysisBarbara Claus, Sabrina Commeyne, Marc Van de Casteele, et al.
Acta Clinica Belgica|July 19, 2016
Abscopal effect in metastatic renal cell carcinomaMieke Van de Walle, Jan Demol, Lorenzo Staelens, et al.
Acta Clinica Belgica|November 1, 2019
Targeting FGFR in bladder cancer: ready for clinical practice?Stijn De Keukeleire, Daan De Maeseneer, Celine Jacobs, et al.
Urologic Oncology|February 25, 2015
Battling resistance mechanisms in antihormonal prostate cancer treatment: Novel agents and combinationsDaan Joost De Maeseneer, Charles Van Praet, Nicolaas Lumen, et al.
Acta Clinica Belgica|June 30, 2016
Therapeutic approaches in clear cell and non-clear cell renal cell carcinomaT Vermassen, A De Meulenaere, M Van de Walle, et al.
Pageof 16